Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Primary objective To evaluate the efficacy of Acarbose add-on therapy on glucose control in
subjects with type 2 diabetes inadequately controlled with Metformin and Sitagliptin
combination therapy.
The effect of acarbose, an alpha glucosidase inhibitor as a third-line therapeutic medication
in subject who are inadequately controlled with metformin and DPP4 inhibitor will be
evaluated with multicenter, randomized, 24-week, double blinded, placebo-controlled study in
Korea.